Skip to main content
. 2020 May 28;14:1753466620926949. doi: 10.1177/1753466620926949

Figure 2.

Figure 2.

E-RS:COPD total score responders (⩾2-point reduction from baseline)

CI, confidence interval; E-RS:COPD, Evaluating Respiratory Symptoms in COPD; OR, odds ratio; SAL, salmeterol; UMEC, umeclidinium; VI, vilanterol.